HEALTH OF WOMAN. 2020.5-6(151-152): 33-37; doi 10.15574/HW.2020.151-152.33
M.A. Flaksenberg
SI «Institute of pediatrics, obstetrics and ginecology named academic Elena. M. Lukyanova NAMS of Ukraine»
Vinnytsia Medical University of the Ministry of Health of Ukraine

The objective: determination of morphofunctional features of leiomatous nodes and endometrium in women with uterine leiomyoma and infertility to restore reproductive function and prevent recurrence of the underlying disease.
Materials and methods. In order to restore reproductive function and prevent recurrence of the underlying disease, morphofunctional features of leiomatous nodes and endometrium in women with uterine leiomyoma and infertility were determined. Thirty samples of leiomyomatous nodes and endometrium were examined, among which 15 were obtained from women with multiple uterine leiomyoma and infertility and 15 samples from women with uterine leiomyoma with isolated uterine leiomyoma.
During the study, a general-histological method was used for staining with hematoxylin-eosin and picrofuxin by van Gizon, as well as immunohistochemical methods.
Histological examination of the endometrium was performed according to conventional protocol, taking into account the day of the menstrual cycle and R.W. Noyes criteria.
Results. In the morphological examination of leiomyomatous nodes in the vast majority of cases the presence of uterine leiomyomas of simple and cell types or their combination was established. In women with multiple uterine leiomyoma, simple-type leiomyoma (53.3%) was predominant, and in patients with isolated leiomyoma the signs of cellular uterine leiomyoma (66.7%) were more frequently found.
In 80.0% of women with uterine leiomyoma revealed pathology of the endometrium, such as glandular and glandular-fibrous polyps, simple and complex atypical endometrial hyperplasia, which confirms the theory about the only pathogenetic mechanisms of the emergence of hyperplastic processes of female organs.
In 66.7% of women with multiple leiomyomas, signs of chronic endometritis have been found, which exacerbates the pathological process and can have a negative impact on the reproductive function, such as secretory endometrial transformation and impaired blastocyst implantation, and explains a much higher percentage of infertility in the group.
Conclusion. In women with impaired reproductive function, patients with uterine leiomyoma, it is necessary to conduct a study of the receptivity of the reproductive organs, namely – the endometrium and leiomatous nodes. This will make it possible to use one or another method of treatment in order to restore reproductive function and prevent recurrence of the underlying disease.
Keywords: infertility, uterine leiomyoma, endometrium, receptive apparatus.

REFERENCES

1. Strizhakov AN, Davyidov AI, Pashkov VM, Lebedev VA. 2011. Dobrokachestvennyie zabolevaniya matki. M, GEOTAR-Media:288.

2. Mohammad Ezzati, John M Norian, James H Segars. 2009. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Women’s Health 5; 4: 413–421. https://doi.org/10.2217/WHE.09.29; PMid:19586433 PMCid:PMC3444289

3. Ischenko AI, Botvin MA, Lanchinskiy VI. 2010. Mioma matki: etiologiya, patogenez, diagnostika, lechenie. M, Izdatelskiy dom Vidar-M:244.

4. Tihomirov AL. 2013. Novyie vozmozhnosti patogeneticheskoy terapii miomy matki. Ginekologiya 15;3:67–69.

5. Savitskiy GA, Savitskiy AG. 2003. Mioma matki. Problemyi patogeneza i patogeneticheskoy terapii. 3-e izd. SPb, Elbi-SPb:236.

6. Aziev OV, Sazonova EO. 2001. Otsenka seksualnoy funktsii posle laparoskopicheskoy gisterektomii. Endoskopiya i alternativnyie podhodyi v hirurgicheskom lechenii zhenskih bolezney. M:100–101.

7. Vihlyaeva EM. 2004. Rukovodstvo po diagnostike i lecheniyu leyomiomy matki. M, MED press-inform:400.

8. Breusenko GV. 2003. Gladkie miotsityi miometriya v periodyi ego uskorennogo rosta v prenatalnom ontogeneze, pri beremennosti i miome matki. Diss. kand. med. nauk. Ivanovo:175.

9. Tatarchuk TF, Kosey NV, Altman IV i dr. 2006. Puti optimizatsii organosohranyayuschey terapii leyomiomyi matki. Mezhdunar. Endokrinol. zhurnal 3(5):10–13.

10. Cramer SF, Hoiszny JA. 1995. Epidemiology of uterine leimyomas. Wiht an etiologic hypothesis. J.Reprod. Med. 40:595–600.

11. Ashrafyan LA, Kiselev VI. 2007. Opuholi reproduktivnyih organov (etiologiya i patogenez). M, «Dimitreyd Grafik Grupp»:216.

12. Sidorova IS. 2003. Mioma matki (sovremennyie problemyi etiologii, patogeneza, diagnostiki i lecheniya). M, MIA:256.

13. Rukovodstvo po endokrinnoy ginekologii. Pod red. EM Vihlyaevoy. 3-e izd., dop. M, OOO «Meditsinskoe informatsionnoe agentstvo». 2006:784.

14. Sidorova IS, Kapustina IN, Levakova SA. 1999. Tsvetovoe dopplerovskoe kartirovanie u bolnyih s miomoy matki. Ultrazvukovaya diagnostika v akusherstve, ginekologii i pediatrii 7;4:308–311.

15. Sozaeva LG, Zaborskiy VM, Kizhaev YuE, Poletova TN. 2013. Kompleksnoe konservativnoe lechenie bolnyih s umerennoy zhelezodefitsitnoy anemiey na fone menorragii s primeneniem Siderala. Akusherstvo i ginekologiya 13;3:93–95.

16. Bakanova AR. 2010. Optimizatsiya vyibora protivoretsidivnoy terapii posle hirurgicheskogo lecheniya miomyi matki u zhenschin reproduktivnogo vozrasta novyie tehnologii v diagnostike i lechenii ginekologicheskih zabolevaniy: materialy kongressa. Moskva:129–130.

17. Kulakova VI. 2014. Novyie podhodyi k lecheniyu miomyi matki. Mnenie eksperta. Problemy reproduktsii 2:57–58.

18. Tihomirov AL, Lubnin DM. 2004. Sovremennyie predstavleniya ob etiologii i patogeneze miomy matki. Voprosy ginekologii, akusherstva i perinatologii 3;6:62–68.

19. Taran FA, Stewart EA, Brucker S. 2013, Sep. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy. Geburtshilfe Frauenheilkd. 73(9):924–931. https://doi.org/10.1055/s-0033-1350840; PMid:24771944 PMCid:PMC3859152

20. Linde VA, Volkov NN, Dobrovolskiy MS i dr. 2010. Mioma matki i miomektomiya. M, SweetGroup:94.

21. Krasnopolskiy VI, Logutova LS, Buyanova SN. 2008. Reproduktivnyie problemyi operirovannoy matki. M, Miklosh:160.

22. Marret H et al. 2010. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J. Obstet. Gynecol. Reprod. Biol. 152:133–137. https://doi.org/10.1016/j.ejogrb.2010.07.016; PMid:20688424

23. Lebedev VA, Davyidov AI, Pashkov VM. 2013. Spornyie i nereshennyie voprosy lecheniya i profilaktiki miomy matki u bolnyh reproduktivnogo perioda. Trudnyi patsient 11(8–9):14–19.

24. Bendifallah S, Brun JL, Fernandez HJ. 2011. Myomectomy for infertile women: the role of surgery. Gynecol Obstet Biol Reprod. 40(8):885–901. https://doi.org/10.1016/j.jgyn.2011.09.014; PMid:22056193

25. Kogan EA, Askolskaya SI, BuryikinaP.N i dr. 2012. Retseptivnost endometriya u zhenschin s miomoy matki. Akusherstvo i ginekologiya 8(2):42–48.

26. Tihomirov AL. 2000. Patogeneticheskoe obosnovanie ranney diagnostiki, lecheniya i profilaktiki miomy matki. Diss. d-ra med. nauk. M:26–28.